The Growing Global Threat Of Antibiotic Resistance Ielts Reading Answers Verified Guide

The economic burden is equally devastating. Treating resistant infections requires prolonged hospital stays, more complex and expensive second- and third-line drugs, and intensive monitoring. This strains healthcare budgets and reduces workplace productivity, potentially costing the global economy trillions of dollars in lost output. The Pipeline Paradox

When penicillin became widely available during the Second World War, it was a medical miracle, rapidly vanquishing the biggest wartime killer – infected wounds. Discovered initially by a French medical student, Ernest Duchesne, in 1896, and then rediscovered by Scottish physician Alexander Fleming in 1928, Penicillium crippled many types of disease-causing bacteria. But just four years after drug companies began mass-producing penicillin in 1943, microbes began appearing that could resist it.

Financially, the crisis places an immense burden on global healthcare systems. Treating drug-resistant infections requires prolonged hospitalizations, complex diagnostic testing, and expensive, secondary lines of medication that often carry severe side effects. Economists predict that if left unchecked, AMR could result in millions of annual deaths and trillions of dollars in lost global economic output by the mid-century mark. Strategic Solutions The economic burden is equally devastating

The Growing Global Threat of Antibiotic Resistance In the arena of modern medicine, few developments have transformed human health as profoundly as the discovery of antibiotics. Since Alexander Fleming accidentally discovered penicillin in 1928, these wonder drugs have saved hundreds of millions of lives, turning once-fatal bacterial infections into routine, treatable ailments. However, this golden era of medicine is facing an unprecedented peril. The rise of antibiotic resistance—often referred to as antimicrobial resistance (AMR)—now stands as one of the greatest public health threats of the 21st century.

Modern surgical procedures would become significantly riskier without effective antibiotics. The Pipeline Paradox When penicillin became widely available

For pharmaceutical companies, the return on investment (ROI) for antibiotics is notoriously low. Unlike chronic medications for hypertension or diabetes, which patients take daily for decades, antibiotics are short-course curative drugs used for a week or two. Furthermore, when a breakthrough antibiotic is discovered, medical guidelines dictate that it should be kept on the shelf as a "last resort" to prevent bacteria from developing resistance to it. Consequently, sales volumes remain low. This economic reality has driven major pharmaceutical firms out of antibiotic research, leaving the field dangerously underfunded. Combating the Threat: A Unified Approach

The consequences of antibiotic resistance extend far beyond laboratory settings, manifesting as a severe burden on global healthcare systems. When first-line antibiotics fail, clinicians are forced to rely on second- and third-line drugs. These alternative treatments are invariably more expensive, require longer courses of administration, and frequently carry more severe side effects for the patient. Financially, the crisis places an immense burden on

Explanation: In Paragraph B, Michael Blum says: "In the 1990s, we've come to a point for certain infections that we don't have agents available." This explicitly confirms that for some bacterial infections, no effective antibiotics remain..

Section D notes: "The development of entirely new classes of antibiotics has stagnated since the late 1980s..."

As we move forward, it is essential to adopt a collaborative approach to addressing antibiotic resistance, involving governments, healthcare professionals, researchers, and individuals. By working together, we can reduce the risk of antibiotic resistance and ensure that these life-saving medicines remain effective for generations to come.

Addressing a borderless threat like AMR requires a coordinated, multi-sectoral global response. The World Health Organization (WHO) has championed the "One Health" approach, an initiative that recognizes the intrinsic link between human health, animal health, and the shared environment. Implementing this framework involves tightening regulations on agricultural antibiotic use, improving sanitisation to prevent infection spread, and educating both healthcare providers and the public on responsible drug usage.